# Willow Biosciences

生物合成CBGA/CBG，与Laurus Labs的API许可 — 工程异戊烯基转移酶（四突变体NphB）.

Source: https://cn.bioecon.ru/companies/willow-biosciences/
Updated: 2026-07-03

- 国家: Canada

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 融资 | 2024年6月通过经纪私募配售筹集$164万 | https://www.newswire.ca/news-releases/willow-announces-multi-product-development-and-licensing-partnership-with-laurus-labs-for-manufacturing-active-pharmaceutical-ingredients-859723834.html, https://www.newswire.ca/news-releases/willow-biosciences-reports-second-quarter-2024-financial-results-and-provides-corporate-update-888140231.html, https://www.stocktitan.net/news/CANSF/willow-biosciences-provides-corporate-update-and-announces-signing-vb50lppqpr0g.html |
| 融资 | 与Laurus Labs合作第一年的研发保证付款$4.0 million | https://newsfile.futunn.com/public/NN-PersistNoticeAttachment/7781/20250325/SEDAR_PLUS/CSA_SEDAR_PLUS_NOTICE_RECORD_ID_2062863.pdf, https://www.newswire.ca/news-releases/willow-announces-multi-product-development-and-licensing-partnership-with-laurus-labs-for-manufacturing-active-pharmaceutical-ingredients-859723834.html, https://www.newswire.ca/news-releases/willow-biosciences-reports-second-quarter-2024-financial-results-and-provides-corporate-update-888140231.html, https://www.proactiveinvestors.com/companies/news/1048764/willow-biosciences-inks-api-manufacturing-deal-with-laurus-labs-1048764.html, https://www.stocktitan.net/news/CANSF/willow-biosciences-provides-corporate-update-and-announces-signing-vb50lppqpr0g.html |
| 产能 | 通过多家CMO进行合同生产，包括发酵产能；具体产能未披露 | https://www.newswire.ca/news-releases/willow-biosciences-announces-expansion-of-its-fermentation-manufacturing-network-and-progress-on-its-cbg-gras-determination-852314417.html, https://www.sedarplus.ca/csa-party/records/document.html?id=119cf111e6001177223c0ecc2c8b7dec7d8639efc281b9aaa94206089895d7ea |
| 认证 | 合同生产合作伙伴持有食品、营养品和制药市场所需的相关认证 | https://www.newswire.ca/news-releases/willow-biosciences-announces-expansion-of-its-fermentation-manufacturing-network-and-progress-on-its-cbg-gras-determination-852314417.html |
| 监管批准 | FutureGrown CBG 已成功完成美国 GRAS 认定所需的毒理学评估；此前与 DEA 及加拿大卫生部的大麻素研究监管许可已被放弃 | https://www.newswire.ca/news-releases/willow-biosciences-announces-expansion-of-its-fermentation-manufacturing-network-and-progress-on-its-cbg-gras-determination-852314417.html, https://www.sedarplus.ca/csa-party/records/document.html?id=119cf111e6001177223c0ecc2c8b7dec7d8639efc281b9aaa94206089895d7ea |
| 生产基地 | 位于加利福尼亚州桑尼维尔的研究设施(约16,000平方英尺);生产通过合同生产组织(CMO)进行 | https://www.sedarplus.ca/csa-party/records/document.html?id=119cf111e6001177223c0ecc2c8b7dec7d8639efc281b9aaa94206089895d7ea |
| 员工人数 | 根据最新报告共有19名员工（Sunnyvale 14名科研/技术人员，Calgary 4名，Sunnyvale 1名） | https://www.sedarplus.ca/csa-party/records/document.html?id=119cf111e6001177223c0ecc2c8b7dec7d8639efc281b9aaa94206089895d7ea |
| 营收 | 2024年营收$466万;2024年第二季度营收$100万 | https://newsfile.futunn.com/public/NN-PersistNoticeAttachment/7781/20250325/SEDAR_PLUS/CSA_SEDAR_PLUS_NOTICE_RECORD_ID_2062863.pdf, https://www.newswire.ca/news-releases/willow-biosciences-reports-second-quarter-2024-financial-results-and-provides-corporate-update-888140231.html, https://www.stocktitan.net/news/CANSF/willow-biosciences-provides-corporate-update-and-announces-signing-vb50lppqpr0g.html |

独立来源: newsfile.futunn.com, newswire.ca, proactiveinvestors.com, sedarplus.ca, stocktitan.net

## 技术

- [生物合成大麻素（CBD 与 THC）](https://cn.bioecon.ru/technology/biosynthetic-cannabinoids-cbd-thc/)